INTERNATIONAL PATENT: IOVANCE BIOTHERAPEUTICS, INC. FILES APPLICATION FOR "TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH A LAG-3 INHIBITOR AND A PD-1 INHIBITOR"

GENEVA, Feb. 18 -- IOVANCE BIOTHERAPEUTICS, INC. (825 Industrial RoadSuite 100San Carlos, California 94070) filed a patent application (PCT/US2025/040935) for "TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH A LAG-3 INHIBITOR AND A PD-1 INHIBITOR" on Aug 06, 2025. With publication no. WO/2026/035866, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VOGT, Frederick G. (c/o Iovance Biotherapeutics, Inc300 Rouse Blvd3rd FloorPhiladelphia, Pennsylvania 19112)

Abstract: A method fo...